Heart failure: the challenge of selecting patients for implantable cardioverter defibrillator therapy

References

• Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N. Engl. J. Med.345(20), 1473–1482 (2001).
   PubMed Web of Science ®Google Scholar
• Gorgels AP, Gijsbers C, Vreede-Swagemakers J, Lousberg A, Wellens HJ. Out-of-hospital cardiac arrest – the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur. Heart J.24(13), 1204–1209 (2003).
   PubMed Web of Science ®Google Scholar
• Cowie MR, Wood DA, Coats AJ et al. Incidence and aetiology of heart failure: a population-based study. Eur. Heart J.20(6), 421–428 (1999).
   PubMed Web of Science ®Google Scholar
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet353(9169), 2001–2007 (1999).
   PubMed Web of Science ®Google Scholar
• Teuteberg JJ, Lewis EF, Nohria A et al. Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J. Card. Fail.12(1), 47–53 (2006).
   PubMedGoogle Scholar
• Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J. Interv. Card. Electrophysiol.14(2), 71–78 (2005).
   PubMedGoogle Scholar
• Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J. Am. Coll. Cardiol.51(21), e1–e62 (2008).
   PubMedGoogle Scholar
• Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N. Engl. J. Med.353(14), 1471–1480 (2005).
   PubMed Web of Science ®Google Scholar
• Foley PW, Addison CE, Whinney SB et al. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines. Pacing Clin. Electrophysiol.32(Suppl. 1), S131–S134 (2009).
   PubMedGoogle Scholar
• A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N. Engl. J. Med.337(22), 1576–1583 (1997).
   PubMed Web of Science ®Google Scholar
• Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation102(7), 748–754 (2000).
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Gent M, Roberts RS et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation101(11), 1297–1302 (2000).
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Hallstrom AP, Cappato R et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur. Heart J.21(24), 2071–2078 (2000).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N. Engl. J. Med.335(26), 1933–1940 (1996).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med.346(12), 877–883 (2002).
   PubMed Web of Science ®Google Scholar
• Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med.352(3), 225–237 (2005).
   PubMed Web of Science ®Google Scholar
• Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N. Engl. J. Med.337(22), 1569–1575 (1997).
   PubMed Web of Science ®Google Scholar
• Buxton AE, Lee KL, Fisher JD et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med.341(25), 1882–1890 (1999).
   PubMed Web of Science ®Google Scholar
• Hohnloser SH, Kuck KH, Dorian P et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N. Engl. J. Med.351(24), 2481–2488 (2004).
   PubMed Web of Science ®Google Scholar
• Kadish A, Dyer A, Daubert JP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N. Engl. J. Med.350(21), 2151–2158 (2004).
   PubMed Web of Science ®Google Scholar
• Strickberger SA, Hummel JD, Bartlett TG et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia – AMIOVIRT. J. Am. Coll. Cardiol.41(10), 1707–1712 (2003).
   PubMed Web of Science ®Google Scholar
• Bansch D, Antz M, Boczor S et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation105(12), 1453–1458 (2002).
   PubMed Web of Science ®Google Scholar
• Goldenberg I, Moss AJ, McNitt S et al. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J. Am. Coll. Cardiol.47(9), 1811–1817 (2006).
   PubMedGoogle Scholar
• Wilber DJ, Zareba W, Hall WJ et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation109(9), 1082–1084 (2004).
   PubMedGoogle Scholar
• Steinbeck G, Andresen D, Seidl K et al. Defibrillator implantation early after myocardial infarction. N. Engl. J. Med.361(15), 1427–1436 (2009).
   PubMed Web of Science ®Google Scholar
• Goldenberg I, Vyas AK, Hall WJ et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J. Am. Coll. Cardiol.51(3), 288–296 (2008).
   PubMed Web of Science ®Google Scholar
• Goldenberg I, Moss AJ, McNitt S et al. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am. J. Cardiol.98(4), 485–490 (2006).
   PubMed Web of Science ®Google Scholar
• Salukhe TV, Dimopoulos K, Sutton R et al. Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications. Circulation109(15), 1848–1853 (2004).
   PubMedGoogle Scholar
• Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med.352(15), 1539–1549 (2005).
   PubMed Web of Science ®Google Scholar
• Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med.350(21), 2140–2150 (2004).
   PubMed Web of Science ®Google Scholar
• Lindenfeld J, Feldman AM, Saxon L et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation115(2), 204–212 (2007).
   PubMed Web of Science ®Google Scholar
• Yao G, Freemantle N, Calvert MJ et al. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur. Heart J.28(1), 42–51 (2007).
   PubMed Web of Science ®Google Scholar
• Maisel WH. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA295(16), 1929–1934 (2006).
   PubMed Web of Science ®Google Scholar
• Chow T, Kereiakes DJ, Onufer J et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J. Am. Coll. Cardiol.52(20), 1607–1615 (2008).
   PubMed Web of Science ®Google Scholar
• Verma A, Kilicaslan F, Martin DO et al. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies. Heart92(2), 190–195 (2006).
   PubMed Web of Science ®Google Scholar
• Christ M, Sharkova J, Bayrakcioglu S et al. B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators. Eur. J. Heart Fail.9(3), 272–279 (2007).
   PubMedGoogle Scholar
• Ghanbari H, Dalloul G, Hasan R et al. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch. Intern. Med.169(16), 1500–1506 (2009).
   PubMedGoogle Scholar
• Stevenson LW, Desai AS. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure. J. Card. Fail.12(6), 407–412 (2006).
   PubMedGoogle Scholar
• Daubert JP, Zareba W, Cannom DS et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J. Am. Coll. Cardiol.51(14), 1357–1365 (2008).
   PubMed Web of Science ®Google Scholar
• Poole JE, Johnson GW, Hellkamp AS et al. Prognostic importance of defibrillator shocks in patients with heart failure. N. Engl. J. Med.359(10), 1009–1017 (2008).
   PubMed Web of Science ®Google Scholar
• Adamson PB, Smith AL, Abraham WT et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation110(16), 2389–2394 (2004).
   PubMed Web of Science ®Google Scholar
• Adamson PB, Magalski A, Braunschweig F et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J. Am. Coll. Cardiol.41(4), 565–571 (2003).
   PubMed Web of Science ®Google Scholar